Informatie:
Fout:
ID
14063
Beschrijving
Subcutaneous-Sublingual Immunotherapy With Depigmented and Polymerized Dermatophagoides Pteronyssinus Allergen Extract; ODM derived from: https://clinicaltrials.gov/show/NCT00622362
Link
https://clinicaltrials.gov/show/NCT00622362
Trefwoorden
Versies (1)
- 23-03-16 23-03-16 -
Geüploaded op
23 maart 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Allergic Asthma NCT00622362
Eligibility Allergic Asthma NCT00622362
- StudyEvent: Eligibility
Similar models
Eligibility Allergic Asthma NCT00622362
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Informed consent
Item
written informed consent signed by the patient and guardian.
boolean
C0021430 (UMLS CUI [1])
House dust mite allergy
Item
positive clinical history of allergy to dust mites.
boolean
C0339808 (UMLS CUI [1])
FEV1 | Bronchodilation
Item
fev1 greater than or equal to 80 percent of the expected value and improvement in fev1 greater than 12 percent after bronchodilation.
boolean
C0748133 (UMLS CUI [1,1])
C3537072 (UMLS CUI [1,2])
C3537072 (UMLS CUI [1,2])
Age
Item
age-between 5 and 14 years.
boolean
C0001779 (UMLS CUI [1])
Sensitization | Hypersensitivity skin testing | Dermatophagoides pteronyssinus | Radioallergosorbent Test
Item
sensitization to dust mites, diagnosed by positive skin tests to dermatophagoides pteronyssinus: wheal size > 3 mm diameter and / or rast (> 0.7 ku / l).
boolean
C1325847 (UMLS CUI [1,1])
C0037296 (UMLS CUI [1,2])
C1122992 (UMLS CUI [1,3])
C0034554 (UMLS CUI [1,4])
C0037296 (UMLS CUI [1,2])
C1122992 (UMLS CUI [1,3])
C0034554 (UMLS CUI [1,4])
Age | Out of range
Item
patients out of the age range.
boolean
C0001779 (UMLS CUI [1,1])
C3845292 (UMLS CUI [1,2])
C3845292 (UMLS CUI [1,2])
immunotherapy
Item
use of immunotherapy during the last four years.
boolean
C0021083 (UMLS CUI [1])
Contraindication | Immunotherapy
Item
any contraindication for the use of immunotherapy in accordance with european allergy and clinical immunology immunotherapy subcommittee criteria:
boolean
C1301624 (UMLS CUI [1,1])
C0021083 (UMLS CUI [1,2])
C0021083 (UMLS CUI [1,2])
Beta-blocker treatment
Item
treatment with ß-blockers
boolean
C0741468 (UMLS CUI [1])
Contraindication | Adrenaline
Item
patients who have a condition in which adrenaline is contraindicated (hyperthyroidism, hypertension, heart disease, etc..).
boolean
C1301624 (UMLS CUI [1,1])
C0014563 (UMLS CUI [1,2])
C0020550 (UMLS CUI [1,3])
C0020538 (UMLS CUI [2])
C0018799 (UMLS CUI [3])
C0014563 (UMLS CUI [1,2])
C0020550 (UMLS CUI [1,3])
C0020538 (UMLS CUI [2])
C0018799 (UMLS CUI [3])
Comorbidity | Immune System Diseases
Item
coexistence of immunopathological diseases (e.g. of the liver, kidney, the nervous system, thyroid gland, rheumatic diseases) in which autoimmune mechanisms play a role
boolean
C0009488 (UMLS CUI [1,1])
C0021053 (UMLS CUI [1,2])
C0023895 (UMLS CUI [1,3])
C0022658 (UMLS CUI [2])
C0027765 (UMLS CUI [3])
C0040128 (UMLS CUI [4])
C0035435 (UMLS CUI [5,1])
C0004364 (UMLS CUI [5,2])
C0021053 (UMLS CUI [1,2])
C0023895 (UMLS CUI [1,3])
C0022658 (UMLS CUI [2])
C0027765 (UMLS CUI [3])
C0040128 (UMLS CUI [4])
C0035435 (UMLS CUI [5,1])
C0004364 (UMLS CUI [5,2])
Immune deficiency disease
Item
patients suffering from immune deficiencies
boolean
C1855771 (UMLS CUI [1])
Serious mental disorders
Item
patients with serious psychiatric / psychological disturbances
boolean
C0205404 (UMLS CUI [1,1])
C0004936 (UMLS CUI [1,2])
C0004936 (UMLS CUI [1,2])
aspirin intolerance
Item
patients aspirin intolerance
boolean
C0004059 (UMLS CUI [1])